Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017
Topics: Research & Development, Antibody Technologies
|
Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies
Topics: Antibody Technologies, Cancer Vaccines
|
Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016
Topics: Antibody Technologies
Regions: India
|
Analytical Tool - Apoptosis in Oncology
Topics: Antibody Technologies, Oncology/Hematology
|
Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies
Topics: Antibody Technologies, Cancer Vaccines
|
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Topics: Antibody Technologies, Autoimmune
|
Competitor Analysis: Antibody-Drug Conjugates (ADC)
Topics: Antibody Technologies
|
Triple Analysis: Cancer Vaccines, Antibodies and Peptides
Topics: Antibody Technologies, Cancer Vaccines
|
Triple Analysis: Prostate Cancer, Antibodies and Peptides
Topics: Antibody Technologies, Drug Discovery, Oncology/Hematology
|
Analytical Tool - Antibodies and Peptides in Oncology
Topics: Antibody Technologies, Oncology/Hematology
|
Triple Analysis: Melanoma, Antibodies and Peptides
Topics: Antibody Technologies, Drug Discovery, Oncology/Hematology
|
Next-Generation Antibody Therapies: Pipeline and Market 2011-2021
Topics: Antibody Technologies
|
Mabs vs. TKIs: Two Paths to Cancer Targeting -White Paper
Topics: Antibody Technologies, Oncology/Hematology
|
Competitor Analysis: Anti-Infective Antibodies
Topics: Antibody Technologies
|
Innovative Technologies and Platforms: Fueling the Engines of Drug Discovery
Topics: Antibody Technologies
|
The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition
Topics: Genomics, Antibody Technologies, Hematology & Oncology, Research & Development, Oncology/Hematology
Regions: Global
|
Emerging Technologies: New Antibody-Based Technologies
Topics: Research & Development, Antibody Technologies
|
Analytical Tool - Cancer Therapeutic Antibodies
Topics: Antibody Technologies, Oncology/Hematology
|
Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Antibodies
Topics: Antibody Technologies, Cancer Vaccines
|
Triple Analysis: Colorectal Cancer, Cancer Vaccines and Antibodies
Topics: Antibody Technologies, Cancer Vaccines
|
Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies
Topics: Antibody Technologies, Cancer Vaccines
|
Triple Analysis: Lymphoma, Prostate Cancer and Antibodies
Topics: Antibody Technologies, Drug Discovery, Oncology/Hematology
|
The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others
Topics: Antibody Technologies
Regions: Global
|
Triple Analysis: Leukemia, Cancer Vaccines and Antibodies
Topics: Antibody Technologies, Cancer Vaccines
|
Triple Analysis: Lymphoma, Cancer Vaccines and Antibodies
Topics: Antibody Technologies, Cancer Vaccines
|
Triple Analysis: Melanoma, Cancer Vaccines and Antibodies
Topics: Antibody Technologies, Cancer Vaccines
|
Therapeutic Monoclonal Antibodies: World Market 2011-2021
Topics: Research & Development, Antibody Technologies
Regions: Global
|
Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market
Topics: Proteomics, Antibody Technologies
|
China Monoclonal Antibody Industry Report, 2010-2011
Topics: Antibody Technologies
Regions: China
|
Pursuing Next-Generation Therapeutic Antibodies as the Next Source of Blockbuster Drugs
Topics: Antibody Technologies, Drug Discovery
|
ProtAb Private Vendor Watchlist Profile: Therapeutic Antibodies for Treating Autoimmune Diseases
Topics: Antibody Technologies, Autoimmune
|
Cancer Biologics Pipeline: Antibodies, Peptides, and Proteins—A Competitive Review
Topics: Proteomics, Antibody Technologies
|
Immunochemicals
Topics: Antibody Technologies
Regions: Global
|
Monoclonal Antibodies: A Segment of Major Growth
Topics: Antibody Technologies
|
World Biological Drugs Market 2011-2021
Topics: Antibody Technologies, Biopharmaceuticals
Regions: Global
|
Apoptosis in Oncology: Drug Pipeline Update 2011
Topics: Antibody Technologies, Oncology/Hematology
|
Antibodies in Oncology: Drug Pipeline Update 2011
Topics: Antibody Technologies, Oncology/Hematology
|
Competitor Analysis: Cancer Antibodies in Early Clinical Development
Topics: Research & Development, Antibody Technologies
|
Angiongenesis Inhibitors and Stimulators
Topics: Research & Development, Antibody Technologies, Drug Discovery, Oncology/Hematology
|
Applied Immune Technologies Private Vendor Watchlist Profile: Antibody-Based Drug Development and Target Discovery
Topics: Antibody Technologies
|
Freedonia Focus on Biologicals
Topics: Antibody Technologies, Vaccines, Biopharmaceuticals
Regions: United States
|
Competitor Analysis: Antibody Therapy of Inflammatory and Autoimmune Diseases
Topics: Antibody Technologies, Autoimmune
|
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Topics: Gene Therapy, Antibody Technologies, Antisense & RNAi Technology, Nanomedicine, Drug Delivery
|
Global Monoclonal Antibody Market Analysis
Topics: Antibody Technologies
Regions: Global
|
Antibody Technology Companies 2010
Topics: Biotechnology Company Reports, Antibody Technologies
|
Antibody Pipeline Database: 1-Year Subscription
Topics: Antibody Technologies
|
Monoclonal Antibodies: 2010
Topics: Antibody Technologies
|
Competitor Analysis: Biosimilar and Biobetter/Biosuperior Antibodies
Topics: Biosimilars, Antibody Technologies
|
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Topics: Antibody Technologies, Rheumatology/Arthritis
|
Innovative Technology Platforms: How They Are Paying Off for Big Pharma and Biotech
Topics: Research & Development, Antibody Technologies, Research & Development
|
